[PHARMA] YoY Cumulative Quarter Result on 30-Jun-2018 [#2]

Stock

[PHARMA] PHARMANIAGA BHD

Announcement Date

17-Aug-2018

Admission Sponsor

Sponsor

Financial Year

31-Dec-2018

Quarter

30-Jun-2018 [#2]

Profit Trend

QoQ- 30.67%

YoY- -19.21%

Quarter Report

PHARMA's Financial Summary

View:

Show?

YoY %

Horiz. %

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Cumulative Result
Revenue	1,970,622	1,465,684	1,387,998	1,200,652	1,136,261	1,090,991	984,749	12.24%
YoY %	34.45%	5.60%	15.60%	5.67%	4.15%	10.79%	-	-
Horiz. %	200.11%	148.84%	140.95%	121.92%	115.39%	110.79%	100.00%	-
PBT	53,768	45,206	42,724	40,677	37,927	48,025	63,668	-2.77%
YoY %	18.94%	5.81%	5.03%	7.25%	-21.03%	-24.57%	-	-
Horiz. %	84.45%	71.00%	67.10%	63.89%	59.57%	75.43%	100.00%	-
Tax	-17,052	-13,184	-13,814	-17,322	-8,918	-13,914	-15,100	2.04%
YoY %	-29.34%	4.56%	20.25%	-94.24%	35.91%	7.85%	-	-
Horiz. %	112.93%	87.31%	91.48%	114.72%	59.06%	92.15%	100.00%	-
NP	36,716	32,022	28,910	23,355	29,009	34,111	48,568	-4.55%
YoY %	14.66%	10.76%	23.79%	-19.49%	-14.96%	-29.77%	-	-
Horiz. %	75.60%	65.93%	59.52%	48.09%	59.73%	70.23%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
NP to SH	36,840	32,378	28,898	22,980	28,443	33,374	48,011	-4.31%
YoY %	13.78%	12.04%	25.75%	-19.21%	-14.77%	-30.49%	-	-
Horiz. %	76.73%	67.44%	60.19%	47.86%	59.24%	69.51%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Tax Rate	31.71%	29.16%	32.33%	42.58%	23.51%	28.97%	23.72%	-
YoY %	8.74%	-9.81%	-24.07%	81.11%	-18.85%	22.13%	-	-
Horiz. %	133.68%	122.93%	136.30%	179.51%	99.11%	122.13%	100.00%	-
Total Cost	1,933,906	1,433,662	1,359,088	1,177,297	1,107,252	1,056,880	936,181	12.84%
YoY %	34.89%	5.49%	15.44%	6.33%	4.77%	12.89%	-	-
Horiz. %	206.57%	153.14%	145.17%	125.76%	118.27%	112.89%	100.00%	-
								-
YoY %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	-
Horiz. %	-	-	-	-	-	-	-	-
Net Worth	357,275	357,891	518,564	519,642	541,894	524,041	527,991	-6.29%
YoY %	-0.17%	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	-	-
Horiz. %	67.67%	67.78%	98.21%	98.42%	102.63%	99.25%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Dividend
Div	30,100	22,204	22,149	23,383	20,742	23,302	36,234	-3.04%
YoY %	35.56%	0.25%	-5.28%	12.73%	-10.99%	-35.69%	-	-
Horiz. %	83.07%	61.28%	61.13%	64.53%	57.24%	64.31%	100.00%	-
Div Payout %	81.71%	68.58%	76.65%	101.76%	72.93%	69.82%	75.47%	-
YoY %	19.15%	-10.53%	-24.68%	39.53%	4.45%	-7.49%	-	-
Horiz. %	108.27%	90.87%	101.56%	134.84%	96.63%	92.51%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Equity
Net Worth	357,275	357,891	518,564	519,642	541,894	524,041	527,991	-6.29%
YoY %	-0.17%	-30.98%	-0.21%	-4.11%	3.41%	-0.75%	-	-
Horiz. %	67.67%	67.78%	98.21%	98.42%	102.63%	99.25%	100.00%	-
NOSH	261,991	261,705	261,229	259,821	259,279	258,913	258,819	0.20%
YoY %	0.11%	0.18%	0.54%	0.21%	0.14%	0.04%	-	-
Horiz. %	101.23%	101.12%	100.93%	100.39%	100.18%	100.04%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Ratio Analysis
NP Margin	1.86%	2.18%	2.08%	1.95%	2.55%	3.13%	4.93%	-
YoY %	-14.68%	4.81%	6.67%	-23.53%	-18.53%	-36.51%	-	-
Horiz. %	37.73%	44.22%	42.19%	39.55%	51.72%	63.49%	100.00%	-
ROE	10.31%	9.05%	5.57%	4.42%	5.25%	6.37%	9.09%	-
YoY %	13.92%	62.48%	26.02%	-15.81%	-17.58%	-29.92%	-	-
Horiz. %	113.42%	99.56%	61.28%	48.62%	57.76%	70.08%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Per Share
RPS	150.58	561.06	532.65	462.11	438.24	421.37	380.48	-14.30%
YoY %	-73.16%	5.33%	15.26%	5.45%	4.00%	10.75%	-	-
Horiz. %	39.58%	147.46%	139.99%	121.45%	115.18%	110.75%	100.00%	-
EPS	2.82	12.39	11.09	8.84	10.97	12.89	18.55	-26.92%
YoY %	-77.24%	11.72%	25.45%	-19.42%	-14.90%	-30.51%	-	-
Horiz. %	15.20%	66.79%	59.78%	47.65%	59.14%	69.49%	100.00%	-
DPS	2.30	8.50	8.50	9.00	8.00	9.00	14.00	-25.97%
YoY %	-72.94%	0.00%	-5.56%	12.50%	-11.11%	-35.71%	-	-
Horiz. %	16.43%	60.71%	60.71%	64.29%	57.14%	64.29%	100.00%	-
NAPS	0.273	1.37	1.99	2.00	2.09	2.024	2.04	-28.45%
YoY %	-80.07%	-31.16%	-0.50%	-4.31%	3.26%	-0.78%	-	-
Horiz. %	13.38%	67.16%	97.55%	98.04%	102.45%	99.22%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Adjusted Per Share Value based on latest NOSH - 259,821
RPS	136.73	101.70	96.31	83.31	78.84	75.70	68.33	12.24%
YoY %	34.44%	5.60%	15.60%	5.67%	4.15%	10.79%	-	-
Horiz. %	200.10%	148.84%	140.95%	121.92%	115.38%	110.79%	100.00%	-
EPS	2.56	2.25	2.01	1.59	1.97	2.32	3.33	-4.28%
YoY %	13.78%	11.94%	26.42%	-19.29%	-15.09%	-30.33%	-	-
Horiz. %	76.88%	67.57%	60.36%	47.75%	59.16%	69.67%	100.00%	-
DPS	2.09	1.54	1.54	1.62	1.44	1.62	2.51	-3.00%
YoY %	35.71%	0.00%	-4.94%	12.50%	-11.11%	-35.46%	-	-
Horiz. %	83.27%	61.35%	61.35%	64.54%	57.37%	64.54%	100.00%	-
NAPS	0.2479	0.2483	0.3598	0.3606	0.376	0.3636	0.3663	-6.29%
YoY %	-0.16%	-30.99%	-0.22%	-4.10%	3.41%	-0.74%	-	-
Horiz. %	67.68%	67.79%	98.23%	98.44%	102.65%	99.26%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Price Multiplier on Financial Quarter End Date
Date	30/06/21	30/06/20	28/06/19	29/06/18	30/06/17	30/06/16	30/06/15	-
Price	5.29	2.22	2.84	2.88	4.58	5.50	7.13	-
P/RPS	3.51	0.40	0.53	0.62	1.05	1.31	1.87	11.05%
YoY %	777.50%	-24.53%	-14.52%	-40.95%	-19.85%	-29.95%	-	-
Horiz. %	187.70%	21.39%	28.34%	33.16%	56.15%	70.05%	100.00%	-
P/EPS	187.92	17.91	25.61	32.56	41.75	42.67	38.44	30.24%
YoY %	949.25%	-30.07%	-21.35%	-22.01%	-2.16%	11.00%	-	-
Horiz. %	488.87%	46.59%	66.62%	84.70%	108.61%	111.00%	100.00%	-
EY	0.53	5.58	3.90	3.07	2.40	2.34	2.60	-23.26%
YoY %	-90.50%	43.08%	27.04%	27.92%	2.56%	-10.00%	-	-
Horiz. %	20.38%	214.62%	150.00%	118.08%	92.31%	90.00%	100.00%	-
DY	0.43	3.83	2.99	3.13	1.75	1.64	1.96	-22.32%
YoY %	-88.77%	28.09%	-4.47%	78.86%	6.71%	-16.33%	-	-
Horiz. %	21.94%	195.41%	152.55%	159.69%	89.29%	83.67%	100.00%	-
P/NAPS	19.38	1.62	1.43	1.44	2.19	2.72	3.50	32.97%
YoY %	1,096.30%	13.29%	-0.69%	-34.25%	-19.49%	-22.29%	-	-
Horiz. %	553.71%	46.29%	40.86%	41.14%	62.57%	77.71%	100.00%	-

	30/06/21	30/06/20	30/06/19	30/06/18	30/06/17	30/06/16	30/06/15	CAGR
Price Multiplier on Announcement Date
Date	20/08/21	19/08/20	23/08/19	17/08/18	16/08/17	19/08/16	17/08/15	-
Price	0.925	4.42	2.66	3.11	4.19	5.62	5.65	-
P/RPS	0.61	0.79	0.50	0.67	0.96	1.33	1.48	-13.72%
YoY %	-22.78%	58.00%	-25.37%	-30.21%	-27.82%	-10.14%	-	-
Horiz. %	41.22%	53.38%	33.78%	45.27%	64.86%	89.86%	100.00%	-
P/EPS	32.86	35.66	23.99	35.16	38.20	43.60	30.46	1.27%
YoY %	-7.85%	48.65%	-31.77%	-7.96%	-12.39%	43.14%	-	-
Horiz. %	107.88%	117.07%	78.76%	115.43%	125.41%	143.14%	100.00%	-
EY	3.04	2.80	4.17	2.84	2.62	2.29	3.28	-1.25%
YoY %	8.57%	-32.85%	46.83%	8.40%	14.41%	-30.18%	-	-
Horiz. %	92.68%	85.37%	127.13%	86.59%	79.88%	69.82%	100.00%	-
DY	2.49	1.92	3.20	2.89	1.91	1.60	2.48	0.06%
YoY %	29.69%	-40.00%	10.73%	51.31%	19.37%	-35.48%	-	-
Horiz. %	100.40%	77.42%	129.03%	116.53%	77.02%	64.52%	100.00%	-
P/NAPS	3.39	3.23	1.34	1.56	2.00	2.78	2.77	3.42%
YoY %	4.95%	141.04%	-14.10%	-22.00%	-28.06%	0.36%	-	-
Horiz. %	122.38%	116.61%	48.38%	56.32%	72.20%	100.36%	100.00%	-

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions

Be the first to like this. Showing 0 of 0 comments

Featured Posts

Moomoo MY

Don't Miss Out: Up to USD1,000 in Our Lucky Draw!

Latest Videos

MQ Market Updates - 15 May 2024

MQ Trader

MQ Trading Signals

2024-05-16 16:15:00

ADX

5 Mins

SELL

2024-05-16 16:15:00

OBV

5 Mins

SELL

2024-05-16 16:10:00

ADX

5 Mins

BUY

2024-05-16 16:00:00

EMA 5

30 Mins

BUY

2024-05-16 15:55:00

EMA 5

5 Mins

SELL

More Trading Signals

Apps

MQ Chat

Send individual or group chats with anyone on i3investor

MQ Trader

Earn MQ Points while trading with MQ Trader

MQ Affiliate

Earn side income from Affiliate Program

MQdemy

Online learning and teaching marketplace

Hot Stocks Today >

TOPGLOV

TOP GLOVE CORPORATION BHD

1000

TASCO

TASCO BERHAD

658

HARTA

HARTALEGA HOLDINGS BHD

564

MPI

MALAYSIAN PACIFIC INDUSTRIES

422

PTRANS

PERAK TRANSIT BERHAD

413

YTLPOWR

YTL POWER INTERNATIONAL BHD

408

HLIND

HONG LEONG INDUSTRIES BHD

406

MYEG

MY E.G. SERVICES BHD

391

MBSB

MALAYSIA BUILDING SOCIETY BHD

339

SUPERMX

SUPERMAX CORPORATION BHD

313

Daily Stocks

TOPGLOV

1.22

-0.04

285,679,300

HSI-CXG

0.23

+0.025

284,311,500

REVENUE

0.235

-0.01

275,783,400

HSI-HUZ

0.205

-0.04

241,099,400

MQTECH

0.015

-0.005

158,602,500

CAREPLS

0.355

-0.025

103,506,900

SINKUNG

0.15

+0.01

99,849,900

MYEG

1.04

+0.01

97,975,900

SUPERMX

1.01

-0.07

93,849,300

HSI-CV8

0.15

+0.015

85,318,600

More active Stocks

MPI

33.50

+0.98

201,600

F&N

33.22

+0.74

295,900

HEIM

24.76

+0.56

368,400

CARLSBG

20.16

+0.54

434,800

UTDPLT

26.14

+0.52

283,000

NESTLE

129.50

+0.50

32,000

PANAMY

19.68

+0.42

21,700

ALLIANZ

22.08

+0.40

37,900

PENTA

4.75

+0.30

4,125,000

KSENG

6.28

+0.30

537,900

More gainer Stocks

AJI

16.12

-0.44

234,900

AIRPORT

10.06

-0.34

26,447,900

KOSSAN

2.49

-0.25

22,781,600

DLADY

32.72

-0.22

2,100

HARTA

3.62

-0.20

36,444,300

KOSSAN-C60

0.585

-0.195

341,000

AHEALTH

2.92

-0.15

822,000

ICAP

3.31

-0.13

409,100

DJIA-HG

0.215

-0.125

200

KUAISHO-C17

0.08

-0.12

58,800

More loser Stocks

Featured Advertisers / Partners

Top Brokers >

AmEquities

Affin Hwang

Rakuten Trade

Hong Leong Bank

Books Review >

Ride The Bull Short The Bear

CS Tan

4.9 / 5.0

This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....

Read More